Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 29;10(1):29.
doi: 10.1186/1546-0096-10-29.

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis

Anne E Tebo  1 , Troy Jaskowski, K Wayne Davis, April Whiting, Bronte Clifford, Andrew Zeft, Bernadette McNally, Harry R Hill, John Bohnsack, Sampath Prahalad
Affiliations

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis

Anne E Tebo et al. Pediatr Rheumatol Online J. .

Abstract

Background: Anti-citrullinated protein/peptide antibodies (ACPA), have high specificity for rheumatoid arthritis (RA). Some children with juvenile idiopathic arthritis (JIA), phenotypically resemble RA and test positive for rheumatoid factor (RF) a characteristic biomarker of RA. We investigated the prevalence of ACPA and its relationship to other serologic markers associated with RA in a well-characterized JIA cohort.

Methods: Cases were 334 children with JIA, 30 of whom had RF + polyarticular JIA. Sera from all cases and 50 healthy pediatric controls were investigated by ELISA at a single time point for anti-cyclic citrullinated peptide (anti-CCP) IgG, RF IgM, IgA and IgG, anti-RA33 IgG, and antinuclear antibodies (ANA). Comparisons between cases and controls were made using Chi-square or Fisher exact tests and T-tests.

Results: The prevalence of RF was 8% among controls, and 12% among cases (ns). The prevalence of ACPA was 2% in controls and 14.3% in cases (OR 8.2, p <0.01). Children who were ACPA-positive and RF-negative (n = 23) had a significantly earlier onset-age (4.6 years vs. 12.1 years, p <0.00001) and had fewer HLA-DRB1 shared epitope alleles than those positive for both RF and ACPA (n = 25). Prevalence of anti-RA33 was not different between cases and controls.

Conclusions: ACPAs are detectable in 14% of children with JIA. Children with positive ACPA but negative RF are frequent, and may define a distinct subset of children with JIA. ACPA testing should be included in the classification of JIA.

PubMed Disclaimer

References

    1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J. et al.International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–392. - PubMed
    1. Avcin T, Cimaz R, Falcini F, Zulian F, Martini G, Simonini G. et al.Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis. 2002;61:608–611. doi: 10.1136/ard.61.7.608. - DOI - PMC - PubMed
    1. Gabay C, Prieur AM, Meyer O. Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis. Ann Rheum Dis. 1993;52:785–789. doi: 10.1136/ard.52.11.785. - DOI - PMC - PubMed
    1. Nesher G, Moore TL, Grisanti MW, el-Najdawi E, Osborn TG. Antiperinuclear factor in juvenile rheumatoid arthritis. Ann Rheum Dis. 1992;51:350–352. doi: 10.1136/ard.51.3.350. - DOI - PMC - PubMed
    1. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd. et al.2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–2581. doi: 10.1002/art.27584. - DOI - PubMed